Alaa Alkhalaf

1.6k total citations
30 papers, 714 citations indexed

About

Alaa Alkhalaf is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alaa Alkhalaf has authored 30 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alaa Alkhalaf's work include Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (6 papers). Alaa Alkhalaf is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (6 papers). Alaa Alkhalaf collaborates with scholars based in Netherlands, United Kingdom and Germany. Alaa Alkhalaf's co-authors include Henk J.G. Bilo, Nanne Kleefstra, G. Sophie Mijnhout, Stephan J. L. Bakker, Boudewijn J. Kollen, Klaas H. Groenier, Gerjan Navis, Rijk O. B. Gans, Kornelis J. J. van Hateren and Joachim Struck and has published in prestigious journals such as PLoS ONE, Diabetes Care and Gut.

In The Last Decade

Alaa Alkhalaf

28 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alaa Alkhalaf Netherlands	14	166	136	135	135	124	30	714
M. Schumer United States	9	101 0.6×	142 1.0×	189 1.4×	269 2.0×	87 0.7×	12	995
Lukáš Pácal Czechia	15	103 0.6×	86 0.6×	51 0.4×	63 0.5×	34 0.3×	33	546
Jin Joo South Korea	14	137 0.8×	178 1.3×	85 0.6×	101 0.7×	46 0.4×	35	706
Jin Young Jeong South Korea	14	135 0.8×	185 1.4×	155 1.1×	95 0.7×	73 0.6×	29	778
Ren Guo China	19	57 0.3×	35 0.3×	69 0.5×	117 0.9×	65 0.5×	62	922
Janusz Solski Poland	14	54 0.3×	94 0.7×	89 0.7×	59 0.4×	31 0.3×	64	540
D Hannak Germany	9	194 1.2×	36 0.3×	45 0.3×	158 1.2×	31 0.3×	19	790
Ana Sánchez Spain	16	172 1.0×	61 0.4×	79 0.6×	271 2.0×	62 0.5×	30	800
William L. Gitomer United States	13	45 0.3×	132 1.0×	46 0.3×	126 0.9×	181 1.5×	21	685
Tomasz W. Kamiński Poland	18	49 0.3×	131 1.0×	81 0.6×	130 1.0×	48 0.4×	67	829

Countries citing papers authored by Alaa Alkhalaf

Since Specialization

Citations

This map shows the geographic impact of Alaa Alkhalaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Alkhalaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Alkhalaf more than expected).

Fields of papers citing papers by Alaa Alkhalaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Alkhalaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Alkhalaf. The network helps show where Alaa Alkhalaf may publish in the future.

Co-authorship network of co-authors of Alaa Alkhalaf

This figure shows the co-authorship network connecting the top 25 collaborators of Alaa Alkhalaf. A scholar is included among the top collaborators of Alaa Alkhalaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaa Alkhalaf. Alaa Alkhalaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duits, Lucas C., Roos E. Pouw, Bas L. Weusten, et al.. (2025). Evaluation of an improved computer-aided detection system for Barrett’s neoplasia in real-world imaging conditions. Endoscopy. 57(12). 1327–1337.

Ven, Steffi E. M. van de, Bas L. Weusten, Lorenza Alvarez Herrero, et al.. (2024). Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett’s neoplasia: a nationwide cohort with pathology reassessment. Endoscopy. 56(8). 559–568. 3 indexed citations

Dang, Hao, Wouter H. de Vos tot Nederveen Cappel, Alaa Alkhalaf, et al.. (2024). T1 colorectal cancer patients' perspective on information provision and therapeutic decision‐making after local resection. United European Gastroenterology Journal. 12(10). 1367–1377. 1 indexed citations

Munster, Sanne N. van, Esther Nieuwenhuis, Lorenza Alvarez Herrero, et al.. (2022). Clinical Relevance of Random Biopsies From the Esophagogastric Junction After Complete Eradication of Barrett’s Esophagus is Low. Clinical Gastroenterology and Hepatology. 21(9). 2260–2269.e9. 7 indexed citations

Herrero, Lorenza Alvarez, Alaa Alkhalaf, Ed Schenk, et al.. (2022). Comparison of focal cryoballoon ablation with 10- and 8-second doses for treatment of Barrett’s esophagus–related neoplasia: results from a prospective European multicenter study (with video). Gastrointestinal Endoscopy. 96(5). 743–751.e4. 4 indexed citations

Munster, Sanne N. van, Esther Nieuwenhuis, Raf Bisschops, et al.. (2022). Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett’s Esophagus With Early Neoplasia. Clinical Gastroenterology and Hepatology. 20(11). 2495–2504.e5. 2 indexed citations

Nieuwenhuis, Esther, Sanne N. van Munster, Wouter L. Curvers, et al.. (2022). Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett’s esophagus diagnosed in community hospitals. Endoscopy. 54(10). 936–944. 9 indexed citations

Smith, Keith, et al.. (2022). Polybromination of naphthalene using bromine over a montmorillonite clay and regioselective synthesis of 2,6-dibromonaphthalene. ARKIVOC. 2022(5). 46–59. 2 indexed citations

Nieuwkerk, Pythia T., Robert C.H. Scheffer, Rogier J. J. de Ridder, et al.. (2022). Barrett Esophagus: Quality of life and factors associated with illness perception. United European Gastroenterology Journal. 10(7). 721–729. 7 indexed citations

10.

Nieuwenhuis, Esther, Sybren L. Meijer, Lodewijk A.A. Brosens, et al.. (2021). Extending treatment criteria for Barrett’s neoplasia: results of a nationwide cohort of 138 endoscopic submucosal dissection procedures. Endoscopy. 54(6). 531–541. 15 indexed citations

11.

Smith, Keith, et al.. (2021). Effects of Structured Solids on Regioselectivity of Dibromination of Naphthalene. Catalysts. 11(5). 540–540. 2 indexed citations

12.

Nieuwenhuis, Esther, Bas L. Weusten, Lorenza Alvarez Herrero, et al.. (2021). Long-term outcomes after endoscopic treatment for Barrett’s neoplasia with radiofrequency ablation ± endoscopic resection: results from the national Dutch database in a 10-year period. Gut. 71(2). 265–276. 57 indexed citations

13.

Pena, Michelle J., Andreas Heinzel, Georg Heinze, et al.. (2015). A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes. PLoS ONE. 10(5). e0120995–e0120995. 50 indexed citations

14.

Riphagen, Ineke J., Nanne Kleefstra, Iefke Drion, et al.. (2015). Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36). PLoS ONE. 10(3). e0120477–e0120477. 9 indexed citations

15.

Gerrits, Esther G., Alaa Alkhalaf, Gijs W.D. Landman, et al.. (2014). Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28). PLoS ONE. 9(2). e89719–e89719. 26 indexed citations

16.

Riphagen, Ineke J., Wendy E. Boertien, Alaa Alkhalaf, et al.. (2013). Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31). Diabetes Care. 36(10). 3201–3207. 48 indexed citations

17.

Drion, Iefke, Kornelis J. J. van Hateren, Hanneke Joosten, et al.. (2012). Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24). Age and Ageing. 41(3). 345–350. 14 indexed citations

18.

Alkhalaf, Alaa, Nanne Kleefstra, Klaas H. Groenier, et al.. (2012). Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy. PLoS ONE. 7(7). e40427–e40427. 41 indexed citations

19.

Alkhalaf, Alaa, Petra Zürbig, Stephan J. L. Bakker, et al.. (2010). Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy. PLoS ONE. 5(10). e13421–e13421. 103 indexed citations

20.

Alkhalaf, Alaa, Willem van Oeveren, Nanne Kleefstra, et al.. (2010). A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy. Diabetes Care. 33(7). 1598–1601. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact